Elisa Fabbrini
ORCID：0000-0002-7285-7789
发表论文 78 篇 · 总被引 9562 次 · h-index 37
代表论文
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events (2017 · Circulation · 被引 505)
- Hepatic Steatosis as a Marker of Metabolic Dysfunction (2015 · Nutrients · 被引 189)
- Metabolically normal obese people are protected from adverse effects following weight gain (2015 · Journal of Clinical Investigation · 被引 168)
- Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program (2019 · Diabetologia · 被引 130)
- Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: Effects of obesity and weight loss (2014 · Obesity · 被引 91)
- Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD (2024 · New England Journal of Medicine · 被引 65)